The 3rd World Congress of Clinical Lipidology to be hosted in the beautiful city of Brisbane, Australia will build on the success of the previous conferences hosted in Budapest and Vienna. The conference is aimed at health care professionals, who would like to increase their knowledge in lipid disorders.

Lipid disorders remain amongst the most important treatable risk factors for cardiovascular diseases. While we have better and better drugs available to treat  dyslipidemias, residual risk remains and many patients do not reach their targets.

This conference aims to deal with all aspects of lipid disorders from diagnosis to treatment, from diet to novel lipid lowering drugs, from adverse events to compliance issues.

Prominent speakers will exchange updated information and guidelines in the treatment of lipid disorders.  Current and future lipid lowering therapies will be discussed in plenary lectures and small workshops by world leaders in lipidology.

Conference attendees will gain unique and powerful insights into the latest research, developments and treatments.  Leading clinicians from around the world will contribute to a cutting edge program that aims to capture the scope and depth of the exciting field of lipidology.

On behalf of the organizing committee I would like to welcome you to the 3rd World Congress of Clinical Lipidology in Brisbane, Australia from February 10-12, 2017.